Last reviewed · How we verify

NCT03902457

Histomorphometric and Tomographic Assessment on the Influence of the Placement of a Collagen Membrane Subjacent the Sinus Mucosa After Maxillary Sinus Floor Augmentation

Completed NA Last updated 5 October 2020
What this trial tests

NA trial testing Maxillary sinus augmentation in Alveolar Bone Loss in 20 participants. Completed in 30 December 2018.

Timeline
3 February 2016
Primary endpoint
30 October 2018
30 December 2018

Quick facts

Lead sponsorARDEC Academy
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment20
Start date3 February 2016
Primary completion30 October 2018
Estimated completion30 December 2018
Sites1 location across Colombia

Drugs / interventions tested

Conditions studied

Sponsor

ARDEC Academy

Who can join

21 and older, any sex, with Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the purpose of the study is to look for differences in dimensional variations of augmented maxillary sinuses with or without the placement of a collagen membrane subjacent the sinus mucosa.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Tomographic evaluation of the influence of the placement of a collagen membrane subjacent to the sinus mucosa during maxillary sinus floor augmentation: a randomized clinical trial.
    Hirota A, Lang NP, Ferri M, Fortich Mesa N, et al · · 2019 · cited 16× · PMID 31423548 · DOI 10.1186/s40729-019-0183-5
  2. Influence on Implant Bone Healing of a Collagen Membrane Placed Subjacent the Sinus Mucosa-A Randomized Clinical Trial on Sinus Floor Elevation.
    Morimoto A, Kobayashi N, Ferri M, Iezzi G, et al · · 2022 · cited 5× · PMID 35735646 · DOI 10.3390/dj10060105

Verify or expand the search:

Other trials of Maxillary sinus augmentation

Trials testing the same drug.

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

Other ARDEC Academy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03902457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing